HCA Holdings Inc (HCA)

HCA Healthcare, Inc. is a U.S.-based healthcare company whose common stock is listed on the NYSE under the symbol HCA. Through its subsidiaries, the company operates a broad network of medical facilities, including hospitals, ambulatory surgery centers, freestanding emergency care sites, urgent care and walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, and home and community-based services providers. Its hospital operations include general and acute care facilities that deliver inpatient, intensive care, cardiac care, emergency treatment, diagnostic services, and a range of outpatient services such as surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded in 1968 and is headquartered in Nashville, Tennessee. It was previously known as HCA Holdings, Inc.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-HCA
$477.59
29.1% Upside
Undervalued
$467.60
26.4% Upside
Undervalued
Great
3.12
0.8%
July 24, 2026
12.1x
-13.0x
1.1x
82.174 B
134.3 B
36.8%
67.4%
2.8
10.0%
116.7%
Valuation • Fair Value

HCA Holdings Inc (NYSE-HCA) Fair Value by Valuation Model

Compare the primary fair value estimate for HCA Holdings Inc (NYSE-HCA) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$477.59

Estimated upside of 29.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$478.68

Discounted cash flow valuation reference.

Ben Graham Formula Value

$339.81

Classic Ben Graham valuation formula reference.

DDM Fair Value

$681.75

Dividend discount model valuation reference.

EPV Fair Value

$232.88

Earnings power value estimate.

Comps Fair Value

$449.24

Comparable-company valuation reference.

Analyst Price Target

$467.60

Analysts imply upside of 26.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for HCA Holdings Inc (NYSE-HCA) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for HCA Holdings Inc (NYSE-HCA)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

76.388 B

Current operating scale indicator.

Revenue Forecast

78.5 B

Forward revenue estimate.

EBITDA

15.566 B

Current operating profitability reference.

EBITDA Forecast

15.764 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review HCA Holdings Inc (NYSE-HCA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for HCA Holdings Inc (NYSE-HCA)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.97

No elevated caution signal from this screen.

Altman Z-Score

2.8

Intermediate risk zone.

FCF / Net Income

116.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for HCA Holdings Inc (NYSE-HCA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for HCA Holdings Inc (NYSE-HCA)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 24, 2026

Days to Earnings

3

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.8%

Income yield reference.

Upcoming Dividend

3.12

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

10.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for HCA Holdings Inc (NYSE-HCA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

HCA Holdings Inc (NYSE-HCA) Stock Forecast & Technical Outlook

Review HCA Holdings Inc (NYSE-HCA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for HCA Holdings Inc (NYSE-HCA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for HCA Holdings Inc (NYSE-HCA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for HCA Holdings Inc (NYSE-HCA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for HCA Holdings Inc (NYSE-HCA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for HCA Holdings Inc (NYSE-HCA) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for HCA Holdings Inc (NYSE-HCA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, HCA Holdings Inc (NYSE-HCA) has a Buy consensus, with 13 buy, 10 hold and 1 sell recommendations in the current data set.

Buy 13
Hold 10
Sell 1
FAQ Fast Investor Answers

HCA Holdings Inc (NYSE-HCA) Stock FAQ

Quick answers about HCA Holdings Inc (NYSE-HCA) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$477.59
Estimated upside 29.1%
Valuation Rating
Undervalued
Estimated upside of 29.1%
Analyst Target
$467.60
Implied upside 26.4%
Financial Health
Great
Current financial-health read

The current fair value estimate for HCA Holdings Inc (NYSE-HCA) is $477.59. This implies an estimated upside of 29.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 29.1% versus the current market price.

The available analyst price target for HCA Holdings Inc (NYSE-HCA) is $467.60. The analyst target implies estimated upside of 26.4%.

The current financial health read for HCA Holdings Inc (NYSE-HCA) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for HCA Holdings Inc (NYSE-HCA) is July 24, 2026.

Based on the current data, dividend yield is 0.8%, upcoming dividend amount is 3.12.

The current P/E ratio listed for HCA Holdings Inc (NYSE-HCA) is 12.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for HCA Holdings Inc is 82.174 B.

The current enterprise value listed for HCA Holdings Inc is 134.3 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for HCA Holdings Inc is NYSE-HCA, and the stock is listed on NYSE.

HCA Holdings Inc (NYSE-HCA) is listed on NYSE.

The current debt-to-total-capital ratio listed for HCA Holdings Inc is 36.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for HCA Holdings Inc is 67.4%. Free float helps investors understand how much of the share base is available for public trading.